News Daily News Symplicity Spyral Approved: FDA Clears Second Renal Denervation System Todd Neale November 20, 2023
News Daily News FDA Approves Paradise Renal Denervation System: What Comes Next? Todd Neale November 08, 2023
News Opinion Editor's Corner AHA 2023 What’s Going to Be Hot at AHA 2023 Shelley Wood November 07, 2023
News Conference News TCT 2023 RADIANCE: 'Modest' Renal Denervation Effect Remains at 6 Months Todd Neale October 31, 2023
News Daily News Sham Procedures in CV Research: What’s Sacrificed for Science? Caitlin E. Cox October 23, 2023
News Conference News HFSA 2023 REBALANCE-HF Uncovers HFpEF Group That Responds to Splanchnic Nerve Ablation Todd Neale October 11, 2023
News Daily News ReCor’s Renal Denervation System Gets Thumbs Up From FDA Advisory Panel L.A. McKeown August 22, 2023
News Conference News TVT 2023 No-Implant Shunt for HF Looks Safe, Feasible in Early Snapshot Michael O'Riordan June 12, 2023
News Conference News EuroPCR 2023 Renal Denervation: Exploring Its Potential Beyond Hypertension Todd Neale May 18, 2023
News Conference News EuroPCR 2023 Two New Renal Denervation Systems Look Good in Uncontrolled BP Todd Neale May 17, 2023
News Conference News THT 2023 More Early Insights Into Interatrial Shunts in HF, but Little to Focus the Field Shelley Wood March 24, 2023
News Conference News THT 2023 Preliminary Results Suggest Benefit of Splanchnic Nerve Ablation in HFpEF Todd Neale March 22, 2023
News Conference News THT 2023 Pulmonary Artery Denervation Makes Inroads in PAH Due to Left-Sided HF Shelley Wood March 21, 2023
News Daily News European Societies Define Best Practices for Performing Renal Denervation Todd Neale February 21, 2023